Literature DB >> 27717991

[Bifurcation lesions : How should they be assessed and treated?]

H M Nef1, O Dörr2, H Möllmann3, A Elsässer4.   

Abstract

Bifurcation lesions are a therapeutic challenge in the interventional treatment of coronary artery disease. Thus, consideration of anatomical aspects and selection of the most appropriate strategy for an individual bifurcation have an impact on the interventional outcome. Accordingly, assessment of the type of bifurcation stenosis, including the relevance of the side branches, vessel diameter and the angle between the two branches are critical for the optimal choice of interventional strategy. The fractional flow reserve (FFR) is a parameter that provides a measure of the severity of coronary stenosis and despite some limitations, FFR can be applied to bifurcation lesions. In addition, intravascular imaging tools, such as intravascular ultrasound (IVUS) and optical coherence tomography (OCT) can be used to determine anatomical configurations.

Entities:  

Keywords:  Coronary bifurcation lesions; Culotte technique; Mini-crush technique; Percutaneous coronary intervention; T and protrusion technique

Mesh:

Year:  2016        PMID: 27717991     DOI: 10.1007/s00059-016-4465-x

Source DB:  PubMed          Journal:  Herz        ISSN: 0340-9937            Impact factor:   1.443


  8 in total

1.  Lack of relation between imaging and physiology in ostial coronary artery narrowings.

Authors:  Ali Ziaee; Walter A Parham; Steven C Herrmann; Richard E Stewart; Michael J Lim; Morton J Kern
Journal:  Am J Cardiol       Date:  2004-06-01       Impact factor: 2.778

2.  [A new classification of coronary bifurcation lesions].

Authors:  Alfonso Medina; José Suárez de Lezo; Manuel Pan
Journal:  Rev Esp Cardiol       Date:  2006-02       Impact factor: 4.753

3.  Technical aspects of the culotte technique.

Authors:  Andrejs Erglis; Jens Flensted Lassen; Carlo Di Mario
Journal:  EuroIntervention       Date:  2015       Impact factor: 6.534

4.  Randomized Comparison of FFR-Guided and Angiography-Guided Provisional Stenting of True Coronary Bifurcation Lesions: The DKCRUSH-VI Trial (Double Kissing Crush Versus Provisional Stenting Technique for Treatment of Coronary Bifurcation Lesions VI).

Authors:  Shao-Liang Chen; Fei Ye; Jun-Jie Zhang; Tian Xu; Nai-Liang Tian; Zhi-Zhong Liu; Song Lin; Shou-Jie Shan; Zhen Ge; Wei You; Yue-Qiang Liu; Xue-Song Qian; Feng Li; Song Yang; Tak W Kwan; Bo Xu; Gregg W Stone
Journal:  JACC Cardiovasc Interv       Date:  2015-03-26       Impact factor: 11.195

Review 5.  Percutaneous coronary intervention for coronary bifurcation disease: 11th consensus document from the European Bifurcation Club.

Authors:  Jens Flensted Lassen; Niels Ramsing Holm; Adrian Banning; Francesco Burzotta; Thierry Lefèvre; Alaide Chieffo; David Hildick-Smith; Yves Louvard; Goran Stankovic
Journal:  EuroIntervention       Date:  2016-05-17       Impact factor: 6.534

6.  Predictors of coronary stent thrombosis: the Dutch Stent Thrombosis Registry.

Authors:  Jochem W van Werkum; Antonius A Heestermans; A Carla Zomer; Johannes C Kelder; Maarten-Jan Suttorp; Benno J Rensing; Jacques J Koolen; B R Guus Brueren; Jan-Henk E Dambrink; Raymond W Hautvast; Freek W Verheugt; Jurriën M ten Berg
Journal:  J Am Coll Cardiol       Date:  2009-04-21       Impact factor: 24.094

7.  Tools & techniques clinical: optimising stenting strategy in bifurcation lesions with insights from in vitro bifurcation models.

Authors:  Nicolas Foin; Alessio Mattesini; Matteo Ghione; Gianni Dall'ara; Sayan Sen; Sukhjinder Nijjer; Ricardo Petraco; Gregory A Sgueglia; Justin E Davies; Carlo Di Mario
Journal:  EuroIntervention       Date:  2013-11       Impact factor: 6.534

8.  Clinical applications of fractional flow reserve in bifurcation lesions.

Authors:  Sang Hyun Park; Bon-Kwon Koo
Journal:  J Geriatr Cardiol       Date:  2012-09       Impact factor: 3.327

  8 in total
  1 in total

Review 1.  [Bifurcation lesions : Are new strategies and devices needed?]

Authors:  Luise Gaede
Journal:  Herz       Date:  2022-10-21       Impact factor: 1.740

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.